Literature DB >> 24217491

Bilateral squamous cell carcinoma of the lacrimal sac.

Nickisa Hodgson1, Katherine Whipple, Jonathan H Lin, Kevin T Brumund, Don O Kikkawa, Bobby S Korn.   

Abstract

A 42-year-old man presented with right-sided epiphora, a fleshy lesion emanating from the right inferior punctum and a painless mass below the medial canthal tendon. Biopsy of the lacrimal sac mass disclosed papillary squamous cell carcinoma in situ. The patient underwent wide local excision with clear surgical margins and remained disease free until 28 months later when he returned with hemorrhagic epiphora of the OS and fullness overlying the left lacrimal sac. Biopsy confirmed papillary squamous cell carcinoma in situ. He underwent similar excision and has remained disease free for 6 months. To the best of the authors' knowledge, this is the first report of bilateral squamous cell carcinoma of the lacrimal sac.

Entities:  

Mesh:

Year:  2013        PMID: 24217491      PMCID: PMC4081470          DOI: 10.1097/IOP.0b013e3182831c2d

Source DB:  PubMed          Journal:  Ophthalmic Plast Reconstr Surg        ISSN: 0740-9303            Impact factor:   1.746


  9 in total

1.  A mass of the right lacrimal sac in a 53-year-old man.

Authors:  Changlee Seo Pang; Janet D Brown; Charles Edgar Ganote; George Anthony Youngberg
Journal:  Arch Pathol Lab Med       Date:  2005-11       Impact factor: 5.534

Review 2.  The causal relation between human papillomavirus and cervical cancer.

Authors:  F X Bosch; A Lorincz; N Muñoz; C J L M Meijer; K V Shah
Journal:  J Clin Pathol       Date:  2002-04       Impact factor: 3.411

3.  The relationship between p16 expression and high-risk human papillomavirus infection in squamous cell carcinomas from sites other than uterine cervix: a study of 137 cases.

Authors:  Erika E Doxtader; Anna-Luise A Katzenstein
Journal:  Hum Pathol       Date:  2011-08-12       Impact factor: 3.466

4.  Incidence of HIV-related anal cancer remains increased despite long-term combined antiretroviral treatment: results from the french hospital database on HIV.

Authors:  Christophe Piketty; Hana Selinger-Leneman; Anne-Marie Bouvier; Aurelien Belot; Murielle Mary-Krause; Claudine Duvivier; Manuela Bonmarchand; Laurent Abramowitz; Dominique Costagliola; Sophie Grabar
Journal:  J Clin Oncol       Date:  2012-10-22       Impact factor: 44.544

5.  Management of lacrimal sac tumours.

Authors:  D N Parmar; G E Rose
Journal:  Eye (Lond)       Date:  2003-07       Impact factor: 3.775

Review 6.  Lacrimal sac tumors.

Authors:  M A Stefanyszyn; A A Hidayat; J J Pe'er; J C Flanagan
Journal:  Ophthalmic Plast Reconstr Surg       Date:  1994-09       Impact factor: 1.746

7.  Human papillomavirus in primary epithelial tumors of the lacrimal sac.

Authors:  S A Madreperla; W R Green; R Daniel; K V Shah
Journal:  Ophthalmology       Date:  1993-04       Impact factor: 12.079

8.  Dormancy of micrometastases: balanced proliferation and apoptosis in the presence of angiogenesis suppression.

Authors:  L Holmgren; M S O'Reilly; J Folkman
Journal:  Nat Med       Date:  1995-02       Impact factor: 53.440

9.  Human papillomavirus: cause of epithelial lacrimal sac neoplasia?

Authors:  Nicolai Christian Sjö; Christian von Buchwald; Patricia Cassonnet; Patricia Flamant; Steffen Heegaard; Bodil Norrild; Jan Ulrik Prause; Gerard Orth
Journal:  Acta Ophthalmol Scand       Date:  2007-03-15
  9 in total
  3 in total

1.  Clinical analysis of 90 cases of malignant lacrimal sac tumor.

Authors:  Xinmao Song; Jie Wang; Shengzi Wang; Weifang Wang; Shuyi Wang; Wenjia Zhu
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2018-04-29       Impact factor: 3.117

2.  Transcatheter arterial infusion chemotherapy and embolization for primary lacrimal sac squamous cell carcinoma: A case report.

Authors:  Ming-Hui Sun; Wei-Dong Yi; Ling Shen; Lu Zhou; Jian-Xun Lu
Journal:  World J Clin Cases       Date:  2022-07-26       Impact factor: 1.534

3.  Squamous cell carcinoma of the lacrimal punctum: A rare presentation.

Authors:  Akshay Gopinathan Nair; Indumati Gopinathan; Vandana Jain
Journal:  Indian J Ophthalmol       Date:  2020-10       Impact factor: 1.848

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.